145 related articles for article (PubMed ID: 22860915)
1. Impact on N-glycosylation profile of monoclonal anti-D antibodies as a way to control their immunoregulatory and cytotoxic properties.
Olovnikova NI; Ershler MA; Grigorieva OV; Petrov AV; Miterev GY
Biochemistry (Mosc); 2012 Aug; 77(8):925-33. PubMed ID: 22860915
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.
Kumpel BM
Vox Sang; 2007 Aug; 93(2):99-111. PubMed ID: 17683353
[TBL] [Abstract][Full Text] [Related]
3. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
4. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
5. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
[TBL] [Abstract][Full Text] [Related]
6. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
7. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
[TBL] [Abstract][Full Text] [Related]
8. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
Leader KA; Kumpel BM; Hadley AG; Bradley BA
Immunology; 1991 Apr; 72(4):481-5. PubMed ID: 1828055
[TBL] [Abstract][Full Text] [Related]
10. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
11. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
[TBL] [Abstract][Full Text] [Related]
12. [EMABling antibodies: from feto-maternal allo-immunisation prophylaxis to chronic lymphocytic leukaemia therapy].
Urbain R; Teillaud JL; Prost JF
Med Sci (Paris); 2009 Dec; 25(12):1141-4. PubMed ID: 20035694
[TBL] [Abstract][Full Text] [Related]
13. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.
Sibéril S; de Romeuf C; Bihoreau N; Fernandez N; Meterreau JL; Regenman A; Nony E; Gaucher C; Glacet A; Jorieux S; Klein P; Hogarth MP; Fridman WH; Bourel D; Béliard R; Teillaud JL
Clin Immunol; 2006; 118(2-3):170-9. PubMed ID: 16332457
[TBL] [Abstract][Full Text] [Related]
14. Do YB2/0 cells produce alien sugars?
Quagliaroli D
Biochemistry (Mosc); 2013 Dec; 78(12):1371-3. PubMed ID: 24460972
[TBL] [Abstract][Full Text] [Related]
15. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.
Mimoto F; Kadono S; Katada H; Igawa T; Kamikawa T; Hattori K
Mol Immunol; 2014 Mar; 58(1):132-8. PubMed ID: 24334029
[TBL] [Abstract][Full Text] [Related]
17. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
[TBL] [Abstract][Full Text] [Related]
18. Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.
Kumpel BM; Saldova R; Koeleman CAM; Abrahams JL; Ederveen AH; Armour KL; Olovnikova NI; Vidarsson G; Kapur R; Rudd PM; Wuhrer M
Sci Rep; 2020 Jan; 10(1):1464. PubMed ID: 32001734
[TBL] [Abstract][Full Text] [Related]
19. Characterization and crystallization of soluble human Fc gamma receptor II (CD32) isoforms produced in insect cells.
Sondermann P; Jacob U; Kutscher C; Frey J
Biochemistry; 1999 Jun; 38(26):8469-77. PubMed ID: 10387093
[TBL] [Abstract][Full Text] [Related]
20. Is an expression system for producing therapeutic antibodies with immunosuppressive properties found at last? Comment to letter by Dr. Quagliaroli.
Olovnikova NI
Biochemistry (Mosc); 2013 Dec; 78(12):1374-5. PubMed ID: 24460973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]